Adalta Capital Management LLC Biogen Inc. Transaction History

Adalta Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $111,960 - $143,885	-500 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$259.0 - $414.71 $77,700 - $124,413	-300 Reduced 37.5%	500 $173,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $176,048 - $243,256	800 New	800 $237,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $175,432 - $193,376	-800 Closed	0 $0
Q3 2017 Nov 24, 2017	BUY	$281.15 - $329.69 $224,919 - $263,752	800	800 $250,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Adalta Capital Management LLC with notifications on news.